ORPHA:528084
Non-specific syndromic intellectual disability
Also known as: Complex neurodevelopmental disorder
Publications
1,456
Trials
13
Interventional, condition-specific
Researchers
1,240
Distinct authors in sample
Gene link
ABCB5, AGO1, ALDH1B1
Definitive
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare genetic characterized by the association of with variable other anomalies in the absence of a well-characterized syndrome. Associated abnormalities may include facial dysmorphism, neurological signs and symptoms, behavioral problems, and abnormalities of various other organ systems.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0100038
- UMLS:C5568766
Additional Mondo synonyms (1)
complex neurodevelopmental disorder
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — ABCB5, AGO1, ALDH1B1, ALDH1L2, ALDOB…
- LiteraturePresent
1,456 matched papers (1,181 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
13 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (ABCB5, AGO1, ALDH1B1…).
GenCC classification: Definitive.
- ABCB5
- AGO1
- ALDH1B1
- ALDH1L2
- ALDOB
- ANK2
- ANKS1B
- ANO4
- AP1G1
- AP2M1
- AP2S1
- ARF3
- ARHGAP33
- ARHGAP35
- ARHGEF6
- ATG4D
- ATP11A
- ATP13A1
- ATP1A3
- ATP6V0A1
- ATXN7L3
- B3GAT3
- BAZ2B
- BLOC1S1
- BORCS5
- BRSK2
- CACNA1D
- CACNA1I
- CACNA2D2
- CACNG2
- CAMK2A
- CAMK2D
- CAMK4
- CAPS2
- CAPZA2
- CC2D1A
- CCDC82
- CCT4
- CCT5
- CCT6A
- CCT7
- CCT8
- CDC42BPB
- CDK20
- CELF2
- CELF4
- CELSR3
- CEP55
- CHAF1A
- CHAMP1
- CHD1
- CHD2
- CHD8
- CHRNA7
- CIC
- CLASP1
- CLCN3
- CNOT1
- CNOT3
- CNOT9
- CNTN2
- CNTN4
- CNTN6
- CNTNAP2
- CNTNAP5
- CPNE6
- CRELD1
- CSDE1
- CSMD1
- CSMD3
- CSNK1G1
- CTNND2
- CUL3
- CYFIP2
- DDX23
- DEAF1
- DENND5B
- DIP2C
- DLG4
- DLGAP2
- DMBX1
- DNAH14
- DNAJA1
- DNAJA3
- DOCK8
- DOP1A
- DPP6
- DRG1
- DSCAML1
- DYRK1A
- EEF1A2
- EIF2AK1
- EIF2AK2
- EIF3I
- EN2
- EPB41L1
- EPHA4
- EXOC2
- EXOC7
- EXOSC4
- EZH1
- FAM177A1
- FBRSL1
- FEM1B
- FEM1C
- FEZF2
- FIBCD1
- FKBP4
- FOXP4
- FRYL
- FSD1L
- GABBR2
- GABRB2
- GABRD
- GIGYF1
- GNAI1
- GON4L
- GPHN
- GPN2
- GRAMD1B
- GRIA1
- GRIK2
- GRIN1
- GRIN2A
- GRIN2B
- GRIN2D
- GTF3C5
- HCN2
- HDAC2
- HDAC3
- HECW2
- HIVEP1
- HNRNPD
- HNRNPL
- HNRNPU
- HNRNPUL2
- INPP4A
- INTS11
- IQSEC2
- ITFG2
- ITSN1
- JMJD1C
- KATNAL2
- KCNA6
- KCNB1
- KCNC1
- KCND2
- KCNQ2
- KCNQ3
- KDM3A
- KDM4B
- KIF1B
- KIF6
- KIRREL3
- KLHL20
- KMT2E
- KMT5B
- KPTN
- LAMC3
- LEO1
- LHX2
- LINS1
- LMAN2L
- LMBRD2
- LMTK3
- LRRC45
- LRRC8A
- MAP4K4
- MBD5
- MBOAT7
- MED13
- MED16
- MED22
- MEF2C
- MET
- METTL4
- MIA3
- MRPL42
- MSL2
- NAV3
- NBEA
- NCKAP1
- NCOR1
- NEUROD1
- NOVA2
- NPAS4
- NR4A2
- NRXN1
- NRXN2
- NTNG1
- NUF2
- OSBPL9
- OTUD7A
- PCDHGA5
- PHF12
- PHF21A
- PHF5A
- PIGA
- PIGO
- PIP5K1C
- PIR
- PLXNA1
- PLXNA2
- POFUT1
- POU3F3
- PPFIA3
- PPP1R12B
- PPP2CA
- PPP2R1A
- PPP2R5C
- PPP2R5D
- PRICKLE2
- PRKD1
- PRMT9
- PSMC3
- PSMD11
- PTRHD1
- PURA
- RAB1A
- RAB35
- RABGAP1
- RALA
- RALGAPA1
- RALGAPB
- RALGDS
- RARS2
- RBL2
- RELN
- REPS2
- RFX3
- RFX7
- RHEB
- RHOBTB2
- RING1
- RORB
- RPH3A
- RREB1
- RSRC1
- RSRC2
- RYBP
- SART3
- SATB1
- SCAF4
- SCAMP5
- SCHIP1
- SCN2A
- SCN8A
- SEMA3E
- SEMA6D
- SETBP1
- SETD1B
- SF3B1
- SGMS1
- SHANK1
- SHANK2
- SHMT2
- SHROOM4
- SIAH1
- SIM1
- SLC12A9
- SLC1A4
- SLC38A12
- SLC4A10
- SLC7A5
- SLCO1C1
- SLIT2
- SLITRK3
- SLK
- SMARCA5
- SMARCB1
- SMURF2
- SNF8
- SNRPA
- SNX27
- SORCS3
- SOX6
- SP9
- SPEN
- SPOUT1
- SRPRA
- SS18L1
- ST3GAL3
- STAG1
- STX1A
- SUN1
- SUPT16H
- SYNGAP1
- TAF1C
- TAOK1
- TBL1XR1
- TBR1
- TCF7L2
- TFE3
- TLK2
- TMEM147
- TMEM63B
- TMPRSS9
- TNRC6B
- TP53TG5
- TRA2B
- TRAPPC6A
- TRERF1
- TRIM23
- TRIP12
- TRMT1
- TTL
- TUBA3E
- TUBAL3
- UNC79
- UNK
- USP14
- USP2
- USP8
- VCP
- WAPL
- WDFY3
- WDFY4
- WDR47
- WDR91
- WSB2
- YWHAE
- YWHAZ
- YY1
- ZBTB18
- ZBTB47
- ZBTB7A
- ZFHX3
- ZFHX4
- ZFTRAF1
- ZMIZ1
- ZNF292
- ZNF407
- ZNF589
- ZNF804A
- ZNRF3
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
1,456
1,456 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
1,456 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
1,181 in the last 10 years · low confidence
Phrase hits: 1,456 · MeSH hits: 0
Who's working on it?
1,240
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Liu Y9 papers · 2026
Department of Pediatrics, Affiliated Hospital of Jiangnan University, Wuxi, People's Republic of China.
Papers in Europe PMC - 02Zhang X8 papers · 2026
State Key Laboratory of Cognitive Neuroscience and Learning and IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China.
Papers in Europe PMC - 03Wang J6 papers · 2026
School of Public Health, Harbin Medical University, Harbin, Heilongjiang, China.
Papers in Europe PMC - 04Chen Z5 papers · 2026
School of Electrical and Information Engineering, Zhengzhou University, Zhengzhou, China.
Papers in Europe PMC - 05Jiang Y5 papers · 2026
Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Papers in Europe PMC - 06Liu X5 papers · 2026
Department of Neurosurgery, Qilu Hospital, Shandong University, Jinan 250012, China; Insititute of Food & Nutrition Science and Technology, Shandong Academy of Agricultural Science, Jinan 250100, China.
Papers in Europe PMC - 07Yang Y5 papers · 2026
School of Public Health, Harbin Medical University, Harbin, Heilongjiang, China.
Papers in Europe PMC - 08Zhang J5 papers · 2026
Department of Pediatrics, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Papers in Europe PMC - 09Chen S4 papers · 2026
Division of Nursing, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Papers in Europe PMC - 10Wang H4 papers · 2026
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
13
interventional trials for this specific condition
13 interventional trials matched this specific condition name; 1 currently recruiting in our sample.
Data as of 27 July 2026
13 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 92.8th percentile).
low confidence · 92.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
13 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07303049·NOT YET RECRUITING·Cognitive Benefit of Intensive Rehabilitation Using Rhythmic Music Training in Children With Complex Neurodevelopmental Disorder
Conditions: Complex Neurodevelopmental Disorder·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Non-specific syndromic intellectual disability" OR "Complex neurodevelopmental disorder"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Non-specific syndromic intellectual disability" OR "Complex neurodevelopmental disorder" OR "ABCB5" OR "AGO1" OR "ALDH1B1"
Recall-expansion terms: ABCB5, AGO1, ALDH1B1
Interventional trials matched via: phrase, recall-expansion (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 13 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1456) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T18:05:17.084Z
